Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)
| ||||||||||||||||||
Abbildung 42: EUROPA-Studie - Subgruppenanalyse Consistency of benefits with perindopril is shown in all patients whether they were using lipid lowering drugs, b-blockers and Calcium-channel blockers, or not. Almost all patients were using platelet inhibitors and more than half of them, lipid lowering drugs. By further analysis, no drug interaction was found meaning that benefits with perindopril are independent of other drugs. |
Abbildung 42: EUROPA-Studie - Subgruppenanalyse
Consistency of benefits with perindopril is shown in all patients whether they were using lipid lowering drugs, b-blockers and Calcium-channel blockers, or not. Almost all patients were using platelet inhibitors and more than half of them, lipid lowering drugs. By further analysis, no drug interaction was found meaning that benefits with perindopril are independent of other drugs. |